Metabolomics-driven insights into metabolic reprogramming underlying traditional Chinese medicine interventions in gastric cancer
Traditional Medicine Research · 2026 · 11 (8) · 55
DOI: 10.53388/tmr20251231001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Traditional Medicine Research, 2026. Verfasst von Adila Maimaiti und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Gastric cancer (GC) remains a significant global health challenge, particularly in East Asia, characterized by high incidence, poor prognosis, and limited therapeutic efficacy in advanced stages. Traditional Chinese medicine (TCM) has emerged as a promising complementary approach for GC treatment, offering multi-target and holistic regulatory effects. Metabolic reprogramming, a hallmark of cancer, plays a pivotal role in GC progression, encompassing dysregulated glycolysis, amino acid, and lipid metabolism. TCM interventions, through their multi-component and system-level modulation, show potential in counteracting these metabolic abnormalities. Metabolomics, a cutting-edge systems biology tool, enables the comprehensive profiling of metabolic alterations and provides mechanistic insights into TCM's pharmacological effects. Recent studies highlight the effectiveness of metabolomics-driven approaches in elucidating the molecular mechanisms of TCM, including the regulation of core metabolic pathways, integration of multi-omics strategies, and modulation of the gut microbiota-metabolite axis. Representative TCM formulas, medicinal herbs, and bioactive compounds have been shown to inhibit glycolytic flux, restore mitochondrial oxidative phosphorylation, rebalance amino acid and lipid metabolism, and modulate tumor microenvironment pathways such as phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) and ferroptosis. Despite these advances, challenges such as heterogeneity in metabolomics platforms and limited clinical validation remain. This review provides a comprehensive overview of metabolomics-driven insights into TCM interventions in GC, highlighting their potential to modernize TCM research and integrate it into precision gastric cancer therapy. Future studies should aim to standardize methodologies, expand clinical validation, and leverage integrative multi-omics to further advance the field.
Zitieren
APA
Maimaiti, A., Xin, H., Wei, Y., Hu, J., Zhang, B., Hou, R., & Song, W. (2026). Metabolomics-driven insights into metabolic reprogramming underlying traditional Chinese medicine interventions in gastric cancer. Traditional Medicine Research, 11(8), 55. https://doi.org/10.53388/tmr20251231001
Vancouver
Maimaiti A, Xin H, Wei Y, Hu J, Zhang B, Hou R, et al. Metabolomics-driven insights into metabolic reprogramming underlying traditional Chinese medicine interventions in gastric cancer. Traditional Medicine Research. 2026;11(8):55. doi:10.53388/tmr20251231001
BibTeX
@article{Maimaiti2026,
author = {Maimaiti, Adila and Xin, Hai-Li and Wei, Yi-Nuo and Hu, Jin and Zhang, Bo and Hou, Rui and Song, Wei},
title = {Metabolomics-driven insights into metabolic reprogramming underlying traditional Chinese medicine interventions in gastric cancer},
journal = {Traditional Medicine Research},
year = {2026},
volume = {11},
number = {8},
pages = {55},
doi = {10.53388/tmr20251231001}
}
EUVIMED